Books published in collaboration (2)
  1. 1. Rosiere, R., Amighi, K., & Wauthoz, N. (2019). Nanotechnology-based targeted drug delivery systems for lung cancer: Nanomedicine-based inhalation treatments for lung cancer.
  2. 2. Wauthoz, N., & Amighi, K. (2015). Pulmonary drug delivery : Advances and Challenges: Formulation strategies for pulmonary drug delivery of poorly soluble drugs. Wiley.
    3.   Contributions to collective works (1)
  3. 1. Wauthoz, N., & Amighi, K. (2015). Formulation strategies for pulmonary delivery of poorly soluble drugs. In Pulmonary Drug Delivery: Advances and Challenges (pp. 87-121). wiley. doi:10.1002/9781118799536.ch5
    4.   Peer-reviewed journal articles (126)
  4. 1. Davenne, T., Percier, P., Larbanoix, L., Moser, M., Leo, O., Meylan, E., Goriely, S., Gérard, P., Wauthoz, N., Laurent, S., Amighi, K., & Rosiere, R. (2022). Inhaled dry powder cisplatin increases antitumour response to anti-PD1 in a murine lung cancer model. Journal of controlled release, 353, 317-326. doi:10.1016/j.jconrel.2022.11.055
  5. 2. Menchi, E., El Khattabi, C., Pochet, S., Denis, O., Amighi, K., & Wauthoz, N. (2022). Optimization of Long-Acting Bronchodilator Dose Ratios Using Isolated Guinea Pig Tracheal Rings for Synergistic Combination Therapy in Asthma and COPD. Pharmaceuticals, 15(8). doi:https://doi.org/10.3390/ ph15080963
  6. 3. Gevenois, P., De Pauw, P., Schoonooghe, S., Delporte, C., Sebti, T., Amighi, K., Muyldermans, S., & Wauthoz, N. (2021). Development of Neutralizing Multimeric Nanobody Constructs Directed against IL-13: From Immunization to Lead Optimization. Journal of immunology (Baltimore, Md. : 1950), 207(10), 2608-2620. doi:10.4049/jimmunol.2100250
  7. 4. Tabare, E., Glonti, T., Cochez, C., Ngassam, C., Pirnay, J.-P., Amighi, K., & Goole, J. (2021). A Design of Experiment Approach to Optimize Spray-Dried Powders Containing Pseudomonas aeruginosa Podoviridae and Myoviridae Bacteriophages. Viruses, 13(10), 1926. doi:10.3390/v13101926
  8. 5. Chraibi, S., Rosiere, R., De Prez, E., Gérard, P., Antoine, M.-H., Langer, I., Nortier, J., Remmelink, M., Amighi, K., & Wauthoz, N. (2021). Preclinical tolerance evaluation of the addition of a cisplatin-based dry powder for inhalation to the conventional carboplatin-paclitaxel doublet for treatment of non-small cell lung cancer. Biomedicine & pharmacotherapy, 139, 111716. doi:10.1016/j.biopha.2021.111716
  9. 6. Chraibi, S., Rosiere, R., Larbanoix, L., Gérard, P., Hennia, I., Laurent, S., Vermeersch, M., Amighi, K., & Wauthoz, N. (2021). The combination of an innovative dry powder for inhalation and a standard cisplatin-based chemotherapy in view of therapeutic intensification against lung tumours. European journal of pharmaceutics and biopharmaceutics, 164, 93-104. doi:10.1016/j.ejpb.2021.04.018
  10. 7. Koubaity, M., Lechon, A.-S., Amighi, K., Van Nuffelen, M., Moreau, M., Meert, A.-P., & De Vriese, C. (2021). Drug-related problems and risk factors related to unplanned hospital readmission among cancer patients in Belgium. Supportive care in cancer. doi:10.1007/s00520-020-05916-w
  11. 8. Chraibi, S., Rosiere, R., De Prez, E., Antoine, M.-H., Remmelink, M., Langer, I., Nortier, J., Amighi, K., & Wauthoz, N. (2021). Pulmonary and renal tolerance of cisplatin-based regimens combining intravenous and endotracheal routes for lung cancer treatment in mice. International journal of pharmaceutics, 599, 120425. doi:10.1016/j.ijpharm.2021.120425
  12. 9. Carlier, E., Marquette, S., Peerboom, C., Amighi, K., & Goole, J. (2021). Development of mAb-loaded 3D-printed (FDM) implantable devices based on PLGA. International journal of pharmaceutics, 597, 120337. doi:10.1016/j.ijpharm.2021.120337
    13. << Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 Next >>